Protocol 402-C-0903: Bardoxolone Methyl Evaluation in Patients with Chronic Kidney Disease and Type 2 Diabetes: The Occurrence of Renal Events

Project: Research project

Project Details

StatusFinished
Effective start/end date4/27/114/27/14

Funding

  • Reata Pharmaceuticals, Inc. (Prot # 402-C-0903)